NCT01185353 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- groups
- description
- Administered orally QD for initial 12 weeks (Part A) followed by randomization to either 4 mg QD or 2 mg BID for an additional 12 weeks (Part B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 4 mg or 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment, participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG000
- title
- 1 mg LY3009104
- description
- Administered orally QD for 24 weeks (Parts A and B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 4 mg or 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment, participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG001
- title
- 2 mg LY3009104
- description
- Administered orally QD for 24 weeks (Parts A and B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 4 mg or 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment, participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG002
- title
- 4 mg LY3009104
- description
- Administered orally QD for 24 weeks (Parts A and B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment, participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG003
- title
- 8 mg LY3009104
- description
- Placebo administered orally QD for initial 12 weeks (Part A) followed by randomization to either 4 mg QD or 2 mg BID for an additional 12 weeks (Part B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 4 mg or 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG004
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.07
- value
- 53.1
- group Id
- BG001
- spread
- 13.12
- value
- 50.7
- group Id
- BG002
- spread
- 10.42
- value
- 52.5
- group Id
- BG003
- spread
- 10.91
- value
- 52.7
- group Id
- BG004
- spread
- 12.15
- value
- 49.2
- group Id
- BG005
- spread
- 11.71
- value
- 51.2
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 44
- group Id
- BG002
- value
- 37
- group Id
- BG003
- value
- 41
- group Id
- BG004
- value
- 85
- group Id
- BG005
- value
- 249
- title
- Female
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 15
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 13
- group Id
- BG005
- value
- 52
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 16
- group Id
- BG005
- value
- 56
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 36
- group Id
- BG003
- value
- 36
- group Id
- BG004
- value
- 78
- group Id
- BG005
- value
- 227
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 18
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 19
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 15
- group Id
- BG005
- value
- 47
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 11
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 37
- group Id
- BG004
- value
- 70
- group Id
- BG005
- value
- 224
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 16
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 31
- group Id
- BG005
- value
- 95
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 13
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Hungary
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 23
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Czech Republic
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 16
- group Id
- BG005
- value
- 47
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Mexico
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 33
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 29
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Ukraine
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 7
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Croatia
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 11
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Romania
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 14
- group Id
- BG005
- value
- 43
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- India
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.885
- value
- 5.45
- group Id
- BG001
- spread
- 4.377
- value
- 5.53
- group Id
- BG002
- spread
- 4.466
- value
- 5.28
- group Id
- BG003
- spread
- 5.048
- value
- 6.63
- group Id
- BG004
- spread
- 4.283
- value
- 5.40
- group Id
- BG005
- spread
- 4.401
- value
- 5.62
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Duration of Rheumatoid Arthritis
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.90
- value
- 21.4
- group Id
- BG001
- spread
- 12.60
- value
- 23.0
- group Id
- BG002
- spread
- 12.71
- value
- 19.9
- group Id
- BG003
- spread
- 13.76
- value
- 24.4
- group Id
- BG004
- spread
- 12.06
- value
- 22.2
- group Id
- BG005
- spread
- 12.38
- value
- 22.2
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- description
- TJC is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both was translated into a single tender-versus-nontender dichotomy.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Tender Joint Counts (TJC)
- unit Of Measure
- number of joints
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 6.55
- value
- 15.2
- group Id
- BG001
- spread
- 9.32
- value
- 17.0
- group Id
- BG002
- spread
- 7.54
- value
- 14.8
- group Id
- BG003
- spread
- 7.92
- value
- 16.1
- group Id
- BG004
- spread
- 8.64
- value
- 15.8
- group Id
- BG005
- spread
- 8.13
- value
- 15.8
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- description
- SJC is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Swollen Joint Counts (SJC)
- unit Of Measure
- number of joints
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.410
- value
- 11.22
- group Id
- BG001
- spread
- 22.111
- value
- 12.02
- group Id
- BG002
- spread
- 16.941
- value
- 11.39
- group Id
- BG003
- spread
- 15.602
- value
- 14.32
- group Id
- BG004
- spread
- 23.527
- value
- 14.03
- group Id
- BG005
- spread
- 19.402
- value
- 12.81
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 97
- group Id
- BG005
- value
- 300
- units
- Participants
- description
- HsCRP is a laboratory analyte that is an indicator of inflammation. Decreases in hsCRP represent reductions in inflammation.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- All randomized participants who received at least one dose of study drug and had evaluable hsCRP data at baseline.
- title
- High Sensitivity C-Reactive Protein (hsCRP)
- unit Of Measure
- milligrams/liter (mg/L)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 17.57
- value
- 38.2
- group Id
- BG001
- spread
- 14.62
- value
- 36.5
- group Id
- BG002
- spread
- 17.16
- value
- 35.4
- group Id
- BG003
- spread
- 18.17
- value
- 43.3
- group Id
- BG004
- spread
- 20.94
- value
- 39.9
- group Id
- BG005
- spread
- 18.39
- value
- 38.8
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- description
- ESR is a laboratory analyte that is an indicator of inflammation. Decreases represent reductions in inflammation.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Erythrocyte Sedimentation Rate (ESR)
- unit Of Measure
- millimeters/hour (mm/hr)
- population Description
- All randomized participants who received at least 1 dose of study drug.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- groups
- description
- Administered orally QD for initial 12 weeks (Part A) followed by randomization to either 4 mg QD or 2 mg BID for an additional 12 weeks (Part B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 4 mg or 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment, participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG000
- title
- 1 mg LY3009104
- description
- Administered orally QD for 24 weeks (Parts A and B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 4 mg or 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment, participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG001
- title
- 2 mg LY3009104
- description
- Administered orally QD for 24 weeks (Parts A and B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 4 mg or 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment, participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG002
- title
- 4 mg LY3009104
- description
- Administered orally QD for 24 weeks (Parts A and B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment, participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG003
- title
- 8 mg LY3009104
- description
- Placebo administered orally QD for initial 12 weeks (Part A) followed by randomization to either 4 mg QD or 2 mg BID for an additional 12 weeks (Part B). After 24 weeks of treatment, participants were eligible to participate in an open-label extension period (Part C). Part C: 4 mg or 8 mg administered orally QD for 52 weeks. After 76 weeks of treatment participants were eligible to participate in an additional open-label extension period (Part D). Part D: 4 mg administered orally QD for 52 additional weeks. MTX was administered orally as background therapy.
- id
- BG004
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG005
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.07
- value
- 53.1
- group Id
- BG001
- spread
- 13.12
- value
- 50.7
- group Id
- BG002
- spread
- 10.42
- value
- 52.5
- group Id
- BG003
- spread
- 10.91
- value
- 52.7
- group Id
- BG004
- spread
- 12.15
- value
- 49.2
- group Id
- BG005
- spread
- 11.71
- value
- 51.2
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 44
- group Id
- BG002
- value
- 37
- group Id
- BG003
- value
- 41
- group Id
- BG004
- value
- 85
- group Id
- BG005
- value
- 249
- title
- Female
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 15
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 13
- group Id
- BG005
- value
- 52
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 16
- group Id
- BG005
- value
- 56
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 36
- group Id
- BG003
- value
- 36
- group Id
- BG004
- value
- 78
- group Id
- BG005
- value
- 227
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 18
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 19
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 15
- group Id
- BG005
- value
- 47
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 11
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 37
- group Id
- BG004
- value
- 70
- group Id
- BG005
- value
- 224
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 16
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 31
- group Id
- BG005
- value
- 95
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 13
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Hungary
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 7
- group Id
- BG005
- value
- 23
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Czech Republic
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 16
- group Id
- BG005
- value
- 47
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Mexico
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 33
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 29
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Ukraine
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 7
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Croatia
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 11
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- Romania
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 14
- group Id
- BG005
- value
- 43
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- title
- India
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.885
- value
- 5.45
- group Id
- BG001
- spread
- 4.377
- value
- 5.53
- group Id
- BG002
- spread
- 4.466
- value
- 5.28
- group Id
- BG003
- spread
- 5.048
- value
- 6.63
- group Id
- BG004
- spread
- 4.283
- value
- 5.40
- group Id
- BG005
- spread
- 4.401
- value
- 5.62
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Duration of Rheumatoid Arthritis
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.90
- value
- 21.4
- group Id
- BG001
- spread
- 12.60
- value
- 23.0
- group Id
- BG002
- spread
- 12.71
- value
- 19.9
- group Id
- BG003
- spread
- 13.76
- value
- 24.4
- group Id
- BG004
- spread
- 12.06
- value
- 22.2
- group Id
- BG005
- spread
- 12.38
- value
- 22.2
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- description
- TJC is the number of tender and painful joints determined for each participant by examination of 68 joints. Joints were assessed by pressure and joint manipulation on physical examination. Participants were asked for pain sensations on these manipulations and watched for spontaneous pain reactions. Any positive response on pressure, movement, or both was translated into a single tender-versus-nontender dichotomy.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Tender Joint Counts (TJC)
- unit Of Measure
- number of joints
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 6.55
- value
- 15.2
- group Id
- BG001
- spread
- 9.32
- value
- 17.0
- group Id
- BG002
- spread
- 7.54
- value
- 14.8
- group Id
- BG003
- spread
- 7.92
- value
- 16.1
- group Id
- BG004
- spread
- 8.64
- value
- 15.8
- group Id
- BG005
- spread
- 8.13
- value
- 15.8
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- description
- SJC is the number of swollen joints determined for each participant by examination of 66 joints. Joints were classified as either swollen or not swollen. Swelling was defined as palpable fluctuating synovitis of the joint.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Swollen Joint Counts (SJC)
- unit Of Measure
- number of joints
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.410
- value
- 11.22
- group Id
- BG001
- spread
- 22.111
- value
- 12.02
- group Id
- BG002
- spread
- 16.941
- value
- 11.39
- group Id
- BG003
- spread
- 15.602
- value
- 14.32
- group Id
- BG004
- spread
- 23.527
- value
- 14.03
- group Id
- BG005
- spread
- 19.402
- value
- 12.81
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 97
- group Id
- BG005
- value
- 300
- units
- Participants
- description
- HsCRP is a laboratory analyte that is an indicator of inflammation. Decreases in hsCRP represent reductions in inflammation.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- All randomized participants who received at least one dose of study drug and had evaluable hsCRP data at baseline.
- title
- High Sensitivity C-Reactive Protein (hsCRP)
- unit Of Measure
- milligrams/liter (mg/L)
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 17.57
- value
- 38.2
- group Id
- BG001
- spread
- 14.62
- value
- 36.5
- group Id
- BG002
- spread
- 17.16
- value
- 35.4
- group Id
- BG003
- spread
- 18.17
- value
- 43.3
- group Id
- BG004
- spread
- 20.94
- value
- 39.9
- group Id
- BG005
- spread
- 18.39
- value
- 38.8
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 50
- group Id
- BG004
- value
- 98
- group Id
- BG005
- value
- 301
- units
- Participants
- description
- ESR is a laboratory analyte that is an indicator of inflammation. Decreases represent reductions in inflammation.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Erythrocyte Sedimentation Rate (ESR)
- unit Of Measure
- millimeters/hour (mm/hr)
- population Description
- All randomized participants who received at least 1 dose of study drug.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle